References

Links to cited work

[1]

Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine

Danilo De Gregorio, Argel Aguilar-Valles, Katrin H. Preller, Boris Dov Heifets, Meghan Hibicke, Jennifer Mitchell, Gabriella Gobbi

Journal of Neuroscience 30 November 2020, JN-SY-1659-20; DOI: 10.1523/JNEUROSCI.1659-20.2020

[2]

Nutt D. Psychedelic drugs-a new era in psychiatry?. Dialogues Clin Neurosci. 2019;21(2):139-147.

doi:10.31887/DCNS.2019.21.2/dnutt